Insmed, Inc. (INSM): Price and Financial Metrics
INSM Price/Volume Stats
Current price | $27.13 | 52-week high | $32.00 |
Prev. close | $27.32 | 52-week low | $16.25 |
Day low | $27.01 | Volume | 1,129,600 |
Day high | $27.55 | Avg. volume | 1,648,874 |
50-day MA | $27.77 | Dividend yield | N/A |
200-day MA | $25.22 | Market Cap | 4.03B |
INSM Stock Price Chart Interactive Chart >
INSM POWR Grades
- INSM scores best on the Value dimension, with a Value rank ahead of 60.33% of US stocks.
- The strongest trend for INSM is in Growth, which has been heading up over the past 26 weeks.
- INSM ranks lowest in Momentum; there it ranks in the 10th percentile.
INSM Stock Summary
- INSMED INC's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than just 5.39% of US listed stocks.
- INSM's price/sales ratio is 14.61; that's higher than the P/S ratio of 92.6% of US stocks.
- Equity multiplier, or assets relative to shareholders' equity, comes in at -14.78 for INSMED INC; that's greater than it is for only 1.74% of US stocks.
- If you're looking for stocks that are quantitatively similar to INSMED INC, a group of peers worth examining would be APLT, CYTK, FGEN, NVAX, and CPTN.
- Visit INSM's SEC page to see the company's official filings. To visit the company's web site, go to www.insmed.com.
INSM Valuation Summary
- INSM's price/earnings ratio is -6.1; this is 120.93% lower than that of the median Healthcare stock.
- INSM's price/sales ratio has moved down 790.2 over the prior 243 months.
Below are key valuation metrics over time for INSM.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
INSM | 2023-12-29 | 15.8 | -15.3 | -6.1 | -8.2 |
INSM | 2023-12-28 | 16.2 | -15.7 | -6.3 | -8.4 |
INSM | 2023-12-27 | 16.1 | -15.6 | -6.3 | -8.4 |
INSM | 2023-12-26 | 15.8 | -15.3 | -6.1 | -8.2 |
INSM | 2023-12-22 | 15.3 | -14.9 | -5.9 | -8.0 |
INSM | 2023-12-21 | 15.0 | -14.5 | -5.8 | -7.9 |
INSM Growth Metrics
- Its 4 year cash and equivalents growth rate is now at 240.87%.
- Its 2 year cash and equivalents growth rate is now at 20.23%.
- Its year over year cash and equivalents growth rate is now at 25.86%.
The table below shows INSM's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-12-31 | 245.358 | -400.439 | -481.534 |
2022-09-30 | 242.182 | -381.422 | -434.389 |
2022-06-30 | 221.209 | -367.039 | -415.958 |
2022-03-31 | 201.354 | -340.182 | -437.634 |
2021-12-31 | 188.461 | -363.302 | -434.654 |
2021-09-30 | 173.752 | -345.962 | -423.889 |
INSM's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- INSM has a Quality Grade of C, ranking ahead of 31.6% of graded US stocks.
- INSM's asset turnover comes in at 0.172 -- ranking 207th of 682 Pharmaceutical Products stocks.
- CYRX, CTLT, and ACOR are the stocks whose asset turnover ratios are most correlated with INSM.
The table below shows INSM's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-09-30 | 0.172 | 0.760 | -0.609 |
2021-06-30 | 0.192 | 0.753 | -0.585 |
2021-03-31 | 0.209 | 0.754 | -0.551 |
2020-12-31 | 0.206 | 0.757 | -0.513 |
2020-09-30 | 0.215 | 0.776 | -0.415 |
2020-06-30 | 0.214 | 0.795 | -0.422 |
INSM Price Target
For more insight on analysts targets of INSM, see our INSM price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $51.78 | Average Broker Recommendation | 1.4 (Strong Buy) |
Insmed, Inc. (INSM) Company Bio
Insmed Incorporated is a biopharmaceutical company focused on developing targeted inhaled therapies for patients suffering from rare lung diseases. The company was founded in 1999 and is based in Bridgewater, New Jersey.
Latest INSM News From Around the Web
Below are the latest news stories about INSMED INC that investors may wish to consider to help them evaluate INSM as an investment opportunity.
Insmed Inc Chief Medical Officer Martina Flammer Sells 28,310 SharesOn December 22, 2023, Martina Flammer, the Chief Medical Officer of Insmed Incorporated (NASDAQ:INSM), sold 28,310 shares of the company's stock, according to a recent SEC Filing. |
Investors ignore increasing losses at Insmed (NASDAQ:INSM) as stock jumps 9.0% this past weekIf you want to compound wealth in the stock market, you can do so by buying an index fund. But in our experience... |
12 Most Promising Stocks to Buy According to Hedge FundsIn this article, we will take a look at the 12 most promising stocks to buy according to hedge funds. To see more such companies, go directly to 5 Most Promising Stocks to Buy According to Hedge Funds. Analysts and financial institutions are starting to release their 2024 market outlook reports and predictions and you […] |
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced the granting of inducement awards to 14 new employees. In accordance with NASDAQ Listing Rule 5635(c)(4), the awards were approved by Insmed's Compensation Committee and made as a material inducement to each employee's entry into employment with the Company. |
Insmed To Present at the Nasdaq 49th Investor ConferenceInsmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will present at the Nasdaq 49th Investor Conference in London on Wednesday, December 6, 2023, at 8:30 a.m. ET/1:30 p.m. GMT. |
INSM Price Returns
1-mo | -3.21% |
3-mo | -12.46% |
6-mo | 7.45% |
1-year | 61.87% |
3-year | -15.95% |
5-year | -6.67% |
YTD | -12.46% |
2023 | 55.11% |
2022 | -26.65% |
2021 | -18.17% |
2020 | 39.41% |
2019 | 82.01% |
Continue Researching INSM
Want to do more research on INSMED Inc's stock and its price? Try the links below:INSMED Inc (INSM) Stock Price | Nasdaq
INSMED Inc (INSM) Stock Quote, History and News - Yahoo Finance
INSMED Inc (INSM) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...